{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:45:52Z","timestamp":1792525552888,"version":"4.5.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No: 82474264, No: 82205044, No: 82174170"],"award-info":[{"award-number":["No: 82474264, No: 82205044, No: 82174170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Eosinophils are multifunctional polymorphonuclear granulocytes garnering attention for their roles in disease and maintaining physiological homeostasis. Historically, these immune cells were known to mediate allergic responses and defend against parasitic infections. Recent evidence further links eosinophils to several eosinophil-associated disorders, including eosinophilic esophagitis, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; however, their pathogenic contribution appears to be disease-specific and remains incompletely defined in some contexts. The advances in immunology and molecular biology have yielded targeted biologic therapies against eosinophils, significantly improving outcomes for patients with eosinophilic disorders. Concurrently, research reveals that eosinophils are a heterogeneous cell population comprising distinct subtypes that differ in surface protein expression, tissue localization, and functional properties. Specifically, resident eosinophils (rEos) reside in tissues for local maintenance and immune regulation, whereas inflammatory eosinophils (iEos) are rapidly recruited during immune responses to drive inflammation. Initially characterized in murine models, similar eosinophil heterogeneity has since been confirmed in human blood and tissues. Recognizing distinct eosinophil subsets is crucial for understanding their contributions to disease progression. This review highlights recent discoveries in eosinophil diversity and explores therapeutic implications of selectively targeting specific eosinophil subsets in clinical practice.<\/jats:p>","DOI":"10.1038\/s41420-026-03234-4","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:34:44Z","timestamp":1783704884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Eosinophil diversity and function: emerging insights into subtypes and therapeutic targets"],"prefix":"10.1038","volume":"12","author":[{"given":"Faiz Ali","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hizbullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mammat","family":"Nurahmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimaitijiang","family":"Abuduwake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naibijiang","family":"Maitusun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-367X","authenticated-orcid":false,"given":"Jingcheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"3234_CR1","first-page":"63","volume":"136","author":"TW Jones","year":"1846","unstructured":"Jones TW. The blood-corpuscle considered in its different phases of development in the animal series. Memoir I.\u2014Vertebrata. Philos Trans R Soc Lond. 1846;136:63\u201387.","journal-title":"Philos Trans R Soc Lond"},{"key":"3234_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1017\/S0025727300056064","volume":"38","author":"DB Brewer","year":"1994","unstructured":"Brewer DB. Max Schultze and the living, moving, phagocytosing leucocytes: 1865. Med Hist. 1994;38:91\u2013101.","journal-title":"Med Hist"},{"key":"3234_CR3","first-page":"571","volume":"3","author":"P Ehrlich","year":"1879","unstructured":"Ehrlich P. \u00dcber die spezifischen Granulationen des Blutes. Arch Physiol. 1879;3:571.","journal-title":"Arch Physiol"},{"key":"3234_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1084\/jem.160.1.179","volume":"160","author":"SA Fischkoff","year":"1984","unstructured":"Fischkoff SA, Pollak A, Gleich GJ, Testa JR, Misawa S, Reber TJ. Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J Exp Med. 1984;160:179\u201396.","journal-title":"J Exp Med"},{"key":"3234_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12016-014-8458-3","volume":"49","author":"JV Weinstock","year":"2015","unstructured":"Weinstock JV. Do we need worms to promote immune health? Clin Rev Allergy Immunol. 2015;49:227\u201331.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3234_CR6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1084\/jem.20020656","volume":"195","author":"C Yu","year":"2002","unstructured":"Yu C, Cantor AB, Yang H, Browne C, Wells RA, Fujiwara Y, et al. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med. 2002;195:1387\u201395.","journal-title":"J Exp Med"},{"key":"3234_CR7","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1084\/jem.20020170","volume":"195","author":"R Hirasawa","year":"2002","unstructured":"Hirasawa R, Shimizu R, Takahashi S, Osawa M, Takayanagi S, Kato Y, et al. Essential and instructive roles of GATA factors in eosinophil development. J Exp Med. 2002;195:1379\u201386.","journal-title":"J Exp Med"},{"key":"3234_CR8","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1182\/blood.V36.4.458.458","volume":"36","author":"MH Boyer","year":"1970","unstructured":"Boyer MH, Basten A, Beeson PB. Mechanism of eosinophilia. 3. Suppression of eosinophilia by agents known to modify immune responses. Blood. 1970;36:458\u201369.","journal-title":"Blood"},{"key":"3234_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/1043-4666(90)90005-E","volume":"2","author":"D Fattah","year":"1990","unstructured":"Fattah D, Quint DJ, Proudfoot A, O\u2019Malley R, Zanders ED, Champion BR. In vitro and in vivo studies with purified recombinant human interleukin 5. Cytokine. 1990;2:112\u201321.","journal-title":"Cytokine"},{"key":"3234_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13032","volume":"93","author":"H Renz","year":"2021","unstructured":"Renz H, Bachert C, Berek C, Hamelmann E, Levi-Schaffer F, Raap U, et al. Physiology and pathology of eosinophils: recent developments: summary of the focus workshop organized by DGAKI. Scand J Immunol. 2021;93:e13032.","journal-title":"Scand J Immunol"},{"key":"3234_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0065-2776(08)01003-1","volume":"101","author":"C Blanchard","year":"2009","unstructured":"Blanchard C, Rothenberg ME. Biology of the eosinophil. Adv Immunol. 2009;101:81\u2013121.","journal-title":"Adv Immunol"},{"key":"3234_CR12","doi-asserted-by":"publisher","first-page":"21539","DOI":"10.1074\/jbc.270.37.21539","volume":"270","author":"HF Rosenberg","year":"1995","unstructured":"Rosenberg HF, Dyer KD. Eosinophil cationic protein and eosinophil-derived neurotoxin. Evolution of novel function in a primate ribonuclease gene family. J Biol Chem. 1995;270:21539\u201344.","journal-title":"J Biol Chem"},{"key":"3234_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.atherosclerosis.2010.02.038","volume":"211","author":"G Niccoli","year":"2010","unstructured":"Niccoli G, Ferrante G, Cosentino N, Conte M, Belloni F, Marino M, et al. Eosinophil cationic protein: a new biomarker of coronary atherosclerosis. Atherosclerosis. 2010;211:606\u201311.","journal-title":"Atherosclerosis"},{"key":"3234_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1067\/mai.2001.114656","volume":"107","author":"AM Piliponsky","year":"2001","unstructured":"Piliponsky AM, Pickholtz D, Gleich GJ, Levi-Schaffer F. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions. J Allergy Clin Immunol. 2001;107:993\u20131000.","journal-title":"J Allergy Clin Immunol"},{"key":"3234_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1042\/BJ20051470","volume":"394","author":"CJ van Dalen","year":"2006","unstructured":"van Dalen CJ, Winterbourn CC, Kettle AJ. Mechanism of nitrite oxidation by eosinophil peroxidase: implications for oxidant production and nitration by eosinophils. Biochem J. 2006;394:707\u201313.","journal-title":"Biochem J"},{"key":"3234_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0891-5849(03)00278-8","volume":"35","author":"AA Andreadis","year":"2003","unstructured":"Andreadis AA, Hazen SL, Comhair SA, Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med. 2003;35:213\u201325.","journal-title":"Free Radic Biol Med"},{"key":"3234_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3389\/fimmu.2014.00496","volume":"5","author":"LA Spencer","year":"2014","unstructured":"Spencer LA, Bonjour K, Melo RC, Weller PF. Eosinophil secretion of granule-derived cytokines. Front Immunol. 2014;5:496.","journal-title":"Front Immunol"},{"key":"3234_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0165-6147(97)01042-0","volume":"18","author":"CG Persson","year":"1997","unstructured":"Persson CG, Erjef\u00e4lt JS. Eosinophil lysis and free granules: an in vivo paradigm for cell activation and drug development. Trends Pharm Sci. 1997;18:117\u201323.","journal-title":"Trends Pharm Sci"},{"key":"3234_CR19","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1164\/ajrccm.161.6.9906085","volume":"161","author":"JS Erjef\u00e4lt","year":"2000","unstructured":"Erjef\u00e4lt JS, Persson CG. New aspects of degranulation and fates of airway mucosal eosinophils. Am J Respir Crit Care Med. 2000;161:2074\u201385.","journal-title":"Am J Respir Crit Care Med"},{"key":"3234_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jaci.2024.12.1069","volume":"155","author":"RCN Melo","year":"2025","unstructured":"Melo RCN, Rothenberg ME. Imaging eosinophil secretory granules: from storage containers to active, immune responder organelles. J Allergy Clin Immunol. 2025;155:414\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"3234_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2024.1448007","volume":"5","author":"T Weihrauch","year":"2024","unstructured":"Weihrauch T, Melo RCN, Gray N, Voehringer D, Weller PF, Raap U. Eosinophil extracellular vesicles and DNA traps in allergic inflammation. Front Allergy. 2024;5:1448007.","journal-title":"Front Allergy"},{"key":"3234_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-019-0868-0","volume":"19","author":"S Ueki","year":"2019","unstructured":"Ueki S, Miyabe Y, Yamamoto Y, Fukuchi M, Hirokawa M, Spencer LA, et al. Charcot-leyden crystals in eosinophilic inflammation: active cytolysis leads to crystal formation. Curr Allergy Asthma Rep. 2019;19:35.","journal-title":"Curr Allergy Asthma Rep"},{"key":"3234_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/jleuko\/qiae079","volume":"116","author":"VH Neves","year":"2024","unstructured":"Neves VH, Palazzi C, Malta KK, Bonjour K, Kneip F, Dias FF, et al. Extracellular sombrero vesicles are hallmarks of eosinophilic cytolytic degranulation in tissue sites of human diseases. J Leukoc Biol. 2024;116:398\u2013408.","journal-title":"J Leukoc Biol"},{"key":"3234_CR24","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3389\/fimmu.2018.01542","volume":"9","author":"LAS Carmo","year":"2018","unstructured":"Carmo LAS, Bonjour K, Spencer LA, Weller PF, Melo RCN. Single-cell analyses of human eosinophils at high resolution to understand compartmentalization and vesicular trafficking of interferon-gamma. Front Immunol. 2018;9:1542.","journal-title":"Front Immunol"},{"key":"3234_CR25","first-page":"391","volume":"27","author":"RA Caruso","year":"2007","unstructured":"Caruso RA, Fedele F, Zuccal\u00e0 V, Fracassi MG, Venuti A. Mast cell and eosinophil interaction in gastric carcinomas: ultrastructural observations. Anticancer Res. 2007;27:391\u20134. P.","journal-title":"Anticancer Res"},{"key":"3234_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/wjo2.138","volume":"10","author":"SY Wu","year":"2023","unstructured":"Wu SY, Cai BY, Wang TY, Cao ZW, Peng H, Liu HH. Eosinophil extracellular traps in respiratory ailment: pathogenic mechanisms and clinical translation. World J Otorhinolaryngol Head Neck Surg. 2023;10:213\u201324.","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"3234_CR27","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20230410","volume":"44","author":"S Zhang","year":"2024","unstructured":"Zhang S, Wang Z. Eosinophil extracellular traps in eosinophilic chronic rhinosinusitis induce Charcot-Leyden crystal formation and eosinophil recruitment. Biosci Rep. 2024;44:BSR20230410.","journal-title":"Biosci Rep"},{"key":"3234_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/imr.12638","volume":"282","author":"PA Robida","year":"2018","unstructured":"Robida PA, Puzzovio PG, Pahima H, Levi-Schaffer F, Bochner BS. Human eosinophils and mast cells: birds of a feather flock together. Immunol Rev. 2018;282:151\u201367.","journal-title":"Immunol Rev"},{"key":"3234_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3389\/fimmu.2017.00510","volume":"8","author":"S Pesce","year":"2017","unstructured":"Pesce S, Thoren FB, Cantoni C, Prato C, Moretta L, Moretta A, et al. The innate immune cross talk between NK cells and eosinophils is regulated by the interaction of natural cytotoxicity receptors with eosinophil surface ligands. Front Immunol. 2017;8:510.","journal-title":"Front Immunol"},{"key":"3234_CR30","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1182\/blood-2012-05-432088","volume":"121","author":"S Ueki","year":"2013","unstructured":"Ueki S, Melo RC, Ghiran I, Spencer LA, Dvorak AM, Weller PF. Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood. 2013;121:2074\u201383.","journal-title":"Blood"},{"key":"3234_CR31","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/labinvest.2009.40","volume":"89","author":"RC Melo","year":"2009","unstructured":"Melo RC, Spencer LA, Perez SA, Neves JS, Bafford SP, Morgan ES, et al. Vesicle-mediated secretion of human eosinophil granule-derived major basic protein. Lab Invest. 2009;89:769\u201381.","journal-title":"Lab Invest"},{"key":"3234_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.yexcr.2016.08.016","volume":"347","author":"RCN Melo","year":"2016","unstructured":"Melo RCN, Weller PF. Vesicular trafficking of immune mediators in human eosinophils revealed by immunoelectron microscopy. Exp Cell Res. 2016;347:385\u201390.","journal-title":"Exp Cell Res"},{"key":"3234_CR33","first-page":"297","volume":"302","author":"LA Spencer","year":"2005","unstructured":"Spencer LA, Melo RC, Perez SA, Weller PF. A gel-based dual antibody capture and detection method for assaying of extracellular cytokine secretion: EliCell. Methods Mol Biol. 2005;302:297\u2013314.","journal-title":"Methods Mol Biol"},{"key":"3234_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1067\/mai.2002.121453","volume":"109","author":"MR Logan","year":"2002","unstructured":"Logan MR, Lacy P, Bablitz B, Moqbel R. Expression of eosinophil target SNAREs as potential cognate receptors for vesicle-associated membrane protein-2 in exocytosis. J Allergy Clin Immunol. 2002;109:299\u2013306.","journal-title":"J Allergy Clin Immunol"},{"key":"3234_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.anai.2014.04.002","volume":"113","author":"GT Furuta","year":"2014","unstructured":"Furuta GT, Atkins FD, Lee NA, Lee JJ. Changing roles of eosinophils in health and disease. Ann Allergy Asthma Immunol. 2014;113:3\u20138.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"3234_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2022.107094","volume":"207","author":"B Hilvering","year":"2023","unstructured":"Hilvering B, Koenderman L. Quality over quantity; eosinophil activation status will deepen the insight into eosinophilic diseases. Respir Med. 2023;207:107094.","journal-title":"Respir Med"},{"key":"3234_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1083\/jcb.31.2.349","volume":"31","author":"F Miller","year":"1966","unstructured":"Miller F, de Harven E, Palade GE. The structure of eosinophil leukocyte granules in rodents and in man. J Cell Biol. 1966;31:349\u201362.","journal-title":"J Cell Biol"},{"key":"3234_CR38","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41385-021-00416-4","volume":"14","author":"JM Felton","year":"2021","unstructured":"Felton JM, Bouffi C, Schwartz JT, Schollaert KL, Malik A, Vallabh S, et al. Aiolos regulates eosinophil migration into tissues. Mucosal Immunol. 2021;14:1271\u201381.","journal-title":"Mucosal Immunol"},{"key":"3234_CR39","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/JLB.3HI0821-432RR","volume":"111","author":"LD Larsen","year":"2022","unstructured":"Larsen LD, Dockstader K, Olbrich CL, Cartwright IM, Spencer LA. Modulation of surface CD11c expression tracks plasticity in murine intestinal tissue eosinophils. J Leukoc Biol. 2022;111:943\u201352.","journal-title":"J Leukoc Biol"},{"key":"3234_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiaf001","volume":"117","author":"DM Gatti","year":"2025","unstructured":"Gatti DM, Reynolds LA. Thymic eosinophils: What are you doing here? J Leukoc Biol. 2025;117:qiaf001.","journal-title":"J Leukoc Biol"},{"key":"3234_CR41","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.4049\/jimmunol.0801581","volume":"183","author":"J Carlens","year":"2009","unstructured":"Carlens J, Wahl B, Ballmaier M, Bulfone-Paus S, F\u00f6rster R, Pabst O. Common gamma-chain-dependent signals confer selective survival of eosinophils in the murine small intestine. J Immunol. 2009;183:5600\u20137.","journal-title":"J Immunol"},{"key":"3234_CR42","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nrgastro.2010.5","volume":"7","author":"N Powell","year":"2010","unstructured":"Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol. 2010;7:146\u201356.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3234_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S1357-4310(99)01635-4","volume":"6","author":"SM Rankin","year":"2000","unstructured":"Rankin SM, Conroy DM, Williams TJ. Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today. 2000;6:20\u20137.","journal-title":"Mol Med Today"},{"key":"3234_CR44","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1067\/mai.2003.1513","volume":"111","author":"S Matsukura","year":"2003","unstructured":"Matsukura S, Kokubu F, Kuga H, Kawaguchi M, Ieki K, Odaka M, et al. Differential regulation of eotaxin expression by IFN-gamma in airway epithelial cells. J Allergy Clin Immunol. 2003;111:1337\u201344.","journal-title":"J Allergy Clin Immunol"},{"key":"3234_CR45","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1172\/JCI119341","volume":"99","author":"CM Lilly","year":"1997","unstructured":"Lilly CM, Nakamura H, Kesselman H, Nagler-Anderson C, Asano K, Garcia-Zepeda EA, et al. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest. 1997;99:1767\u201373.","journal-title":"J Clin Invest"},{"key":"3234_CR46","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.4049\/jimmunol.161.11.6139","volume":"161","author":"I Sabroe","year":"1998","unstructured":"Sabroe I, Conroy DM, Gerard NP, Li Y, Collins PD, Post TW, et al. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo. J Immunol. 1998;161:6139\u201347.","journal-title":"J Immunol"},{"key":"3234_CR47","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jlb.62.5.667","volume":"62","author":"JR White","year":"1997","unstructured":"White JR, Imburgia C, Dul E, Appelbaum E, O\u2019Donnell K, O\u2019Shannessy DJ, et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukoc Biol. 1997;62:667\u201375.","journal-title":"J Leukoc Biol"},{"key":"3234_CR48","doi-asserted-by":"publisher","first-page":"16418","DOI":"10.1073\/pnas.0607863103","volume":"103","author":"PC Fulkerson","year":"2006","unstructured":"Fulkerson PC, Fischetti CA, McBride ML, Hassman LM, Hogan SP, Rothenberg ME. A central regulatory role for eosinophils and the eotaxin\/CCR3 axis in chronic experimental allergic airway inflammation. Proc Natl Acad Sci USA. 2006;103:16418\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3234_CR49","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.4049\/jimmunol.0904126","volume":"185","author":"T Nakayama","year":"2010","unstructured":"Nakayama T, Watanabe Y, Oiso N, Higuchi T, Shigeta A, Mizuguchi N, et al. Eotaxin-3\/CC chemokine ligand 26 is a functional ligand for CX3CR1. J Immunol. 2010;185:6472\u20139.","journal-title":"J Immunol"},{"key":"3234_CR50","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11154-018-9451-6","volume":"19","author":"KJ Chung","year":"2018","unstructured":"Chung KJ, Nati M, Chavakis T, Chatzigeorgiou A. Innate immune cells in the adipose tissue. Rev Endocr Metab Disord. 2018;19:283\u201392.","journal-title":"Rev Endocr Metab Disord"},{"key":"3234_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cytogfr.2019.05.003","volume":"47","author":"HK Kandikattu","year":"2019","unstructured":"Kandikattu HK, Upparahalli Venkateshaiah S, Mishra A. Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases. Cytokine Growth Factor Rev. 2019;47:83\u201398.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3234_CR52","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ccell.2022.11.014","volume":"41","author":"OS Blomberg","year":"2023","unstructured":"Blomberg OS, Spagnuolo L, Garner H, Voorwerk L, Isaeva OI, van Dyk E, et al. IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer. Cancer Cell. 2023;41:106\u2013123.e10.","journal-title":"Cancer Cell"},{"key":"3234_CR53","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1398-9995.2011.02694.x","volume":"66","author":"N Roth","year":"2011","unstructured":"Roth N, St\u00e4dler S, Lemann M, H\u00f6sli S, Simon HU, Simon D. Distinct eosinophil cytokine expression patterns in skin diseases - the possible existence of functionally different eosinophil subpopulations. Allergy. 2011;66:1477\u201386.","journal-title":"Allergy"},{"key":"3234_CR54","doi-asserted-by":"publisher","first-page":"00813-2024","DOI":"10.1183\/23120541.00813-2024","volume":"11","author":"J Pesic","year":"2025","unstructured":"Pesic J, Nieto Fontarigo JJ, Tillgren SM, Migu\u00e9ns Su\u00e1rez P, Cerps S, Pardali K, et al. Inhibition of IL-4R\u03b1 reduces CCL26 in bronchial epithelial cells from COPD patients. ERJ Open Res. 2025;11:00813-2024.","journal-title":"ERJ Open Res"},{"key":"3234_CR55","doi-asserted-by":"publisher","first-page":"214","DOI":"10.7861\/clinmedicine.1-3-214","volume":"1","author":"AJ Wardlaw","year":"2001","unstructured":"Wardlaw AJ. Eosinophil trafficking in asthma. Clin Med (Lond). 2001;1:214\u20138.","journal-title":"Clin Med (Lond)"},{"key":"3234_CR56","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.immuni.2019.03.022","volume":"50","author":"M Dougan","year":"2019","unstructured":"Dougan M, Dranoff G, Dougan SK. GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation. Immunity. 2019;50:796\u2013811.","journal-title":"Immunity"},{"key":"3234_CR57","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221435","volume":"220","author":"A Gurtner","year":"2023","unstructured":"Gurtner A, Crepaz D, Arnold IC. Emerging functions of tissue-resident eosinophils. J Exp Med. 2023;220:e20221435.","journal-title":"J Exp Med"},{"key":"3234_CR58","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/cid\/ciab920","volume":"75","author":"PH Kuo","year":"2022","unstructured":"Kuo PH, Wu UI, Pan YH, Wang JT, Wang YC, Sun HY, et al. Neutralizing anti-granulocyte-macrophage colony-stimulating factor autoantibodies in patients with central nervous system and localized cryptococcosis: longitudinal follow-up and literature review. Clin Infect Dis. 2022;75:278\u201387.","journal-title":"Clin Infect Dis"},{"key":"3234_CR59","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1097\/j.pbj.0000000000000155","volume":"7","author":"I Paci\u00eancia","year":"2022","unstructured":"Paci\u00eancia I, Rocha AR, Farraia M, Sokhatska O, Delgado L, Couto M, et al. Eosinophil cationic protein (ECP) correlates with eosinophil cell counts in the induced sputum of elite swimmers. Porto Biomed J. 2022;7:e155.","journal-title":"Porto Biomed J"},{"key":"3234_CR60","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.1164\/ajrccm.157.5.rsaa-5","volume":"157","author":"WR Roche","year":"1998","unstructured":"Roche WR. Inflammatory and structural changes in the small airways in bronchial asthma. Am J Respir Crit Care Med. 1998;157:S191\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"3234_CR61","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nm.1855","volume":"14","author":"S Yousefi","year":"2008","unstructured":"Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, Kozlowski E, et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med. 2008;14:949\u201353.","journal-title":"Nat Med"},{"key":"3234_CR62","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/14728222.2020.1783242","volume":"24","author":"GM Gauvreau","year":"2020","unstructured":"Gauvreau GM, Sehmi R, Ambrose CS, Griffiths JM. Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma. Expert Opin Ther Targets. 2020;24:777\u201392.","journal-title":"Expert Opin Ther Targets"},{"key":"3234_CR63","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ni.2104","volume":"12","author":"JM Mj\u00f6sberg","year":"2011","unstructured":"Mj\u00f6sberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011;12:1055\u201362.","journal-title":"Nat Immunol"},{"key":"3234_CR64","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jaci.2017.09.022","volume":"141","author":"JA O\u2019Sullivan","year":"2018","unstructured":"O\u2019Sullivan JA, Bochner BS. Eosinophils and eosinophil-associated diseases: an update. J Allergy Clin Immunol. 2018;141:505\u201317.","journal-title":"J Allergy Clin Immunol"},{"key":"3234_CR65","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/cells11010141","volume":"11","author":"AS Archambault","year":"2022","unstructured":"Archambault AS, Brassard J, Bernatchez \u00c9, Martin C, Di Marzo V, Laviolette M, et al. Human and mouse eosinophils differ in their ability to biosynthesize eicosanoids, docosanoids, the endocannabinoid 2-arachidonoyl-glycerol and its congeners. Cells. 2022;11:141.","journal-title":"Cells"},{"key":"3234_CR66","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0091-6749(96)80061-3","volume":"97","author":"H Kita","year":"1996","unstructured":"Kita H. The eosinophil: A cytokine-producing cell? J Allergy Clin Immunol. 1996;97:889\u201392.","journal-title":"J Allergy Clin Immunol"},{"key":"3234_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54780-3","volume":"15","author":"KF Troch","year":"2024","unstructured":"Troch KF, Jakob MO, Forster PM, Jarick KJ, Schreiber J, Preusser A, et al. Group 2 innate lymphoid cells are a non-redundant source of interleukin-5 required for development and function of murine B1 cells. Nat Commun. 2024;15:10566.","journal-title":"Nat Commun"},{"key":"3234_CR68","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1172\/JCI85664","volume":"126","author":"C Mesnil","year":"2016","unstructured":"Mesnil C, Raulier S, Paulissen G, Xiao X, Birrell MA, Pirottin D, et al. Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J Clin Invest. 2016;126:3279\u201395.","journal-title":"J Clin Invest"},{"key":"3234_CR69","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/all.12776","volume":"71","author":"H Abdala Valencia","year":"2016","unstructured":"Abdala Valencia H, Loffredo LF, Misharin AV, Berdnikovs S. Phenotypic plasticity and targeting of Siglec-F(high) CD11c(low) eosinophils to the airway in a murine model of asthma. Allergy. 2016;71:267\u201371.","journal-title":"Allergy"},{"key":"3234_CR70","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/jleuko\/qiac009","volume":"113","author":"M Shah","year":"2023","unstructured":"Shah M, Knights AJ, Vohralik EJ, Psaila AM, Quinlan KGR. Blood and adipose-resident eosinophils are defined by distinct transcriptional profiles. J Leukoc Biol. 2023;113:191\u2013202.","journal-title":"J Leukoc Biol"},{"key":"3234_CR71","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41586-022-05628-7","volume":"615","author":"A Gurtner","year":"2023","unstructured":"Gurtner A, Borrelli C, Gonzalez-Perez I, Bach K, Acar IE, N\u00fa\u00f1ez NG, et al. Active eosinophils regulate host defence and immune responses in colitis. Nature. 2023;615:151\u20137.","journal-title":"Nature"},{"key":"3234_CR72","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1126\/science.ade4177","volume":"381","author":"Y Li","year":"2023","unstructured":"Li Y, Liu S, Zhou K, Wang Y, Chen Y, Hu W, et al. Neuromedin U programs eosinophils to promote mucosal immunity of the small intestine. Science. 2023;381:1189\u201396.","journal-title":"Science"},{"key":"3234_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/imm.13610","volume":"169","author":"S Albinsson","year":"2023","unstructured":"Albinsson S, Lingblom C, Lundqvist C, Hennings V, Telemo E, Ekwall O, et al. Distinct populations of eosinophils in the human thymus with capacity to modulate thymocyte maturation. Immunology. 2023;169:57\u201368.","journal-title":"Immunology"},{"key":"3234_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.802839","volume":"12","author":"A Dolitzky","year":"2021","unstructured":"Dolitzky A, Shapira G, Grisaru-Tal S, Hazut I, Avlas S, Gordon Y, et al. Transcriptional profiling of mouse eosinophils identifies distinct gene signatures following cellular activation. Front Immunol. 2021;12:802839.","journal-title":"Front Immunol"},{"key":"3234_CR75","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.jaci.2025.11.011","volume":"157","author":"CD Nazaroff","year":"2026","unstructured":"Nazaroff CD, Kienzl M, Schutte CA, LeSuer WE, Ochkur SI, Folmes CDL, et al. IRF1 Is an upstream regulatory transcription factor of eosinophils in type 1 environments. J Allergy Clin Immunol. 2026;157:1162\u201378.","journal-title":"J Allergy Clin Immunol"},{"key":"3234_CR76","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/imcb.12819","volume":"102","author":"SL Noble","year":"2024","unstructured":"Noble SL, Mules TC, Le Gros G, Inns S. The immunoregulatory potential of eosinophil subsets. Immunol Cell Biol. 2024;102:775\u201386.","journal-title":"Immunol Cell Biol"},{"key":"3234_CR77","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1111\/all.15859","volume":"78","author":"S Pantelyushin","year":"2023","unstructured":"Pantelyushin S, Rhiner T, Jebbawi F, Sella F, Waldern N, Lam J, et al. Interleukin 5-dependent inflammatory eosinophil subtype involved in allergic insect bite hypersensitivity of horses. Allergy. 2023;78:3020\u20133.","journal-title":"Allergy"},{"key":"3234_CR78","doi-asserted-by":"publisher","unstructured":"Matucci A, Accinno M, Maggiore G, Brugnoli B, Vivarelli E, Cosmi L, et al. Mepolizumab reduces inflammatory eosinophils in nasal polyp tissue and restores histological alterations. J Investig Allergol Clin Immunol. 2025;36. https:\/\/doi.org\/10.18176\/jiaci.1095.","DOI":"10.18176\/jiaci.1095"},{"key":"3234_CR79","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1111\/all.15909","volume":"78","author":"A Vultaggio","year":"2023","unstructured":"Vultaggio A, Accinno M, Vivarelli E, Mecheri V, Maggiore G, Cosmi L, et al. Blood CD62Llow inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab. Allergy. 2023;78:3154\u201365.","journal-title":"Allergy"},{"key":"3234_CR80","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1164\/rccm.202301-0149OC","volume":"208","author":"C Cabrera L\u00f3pez","year":"2023","unstructured":"Cabrera L\u00f3pez C, S\u00e1nchez Santos A, Lemes Castellano A, Cazorla Rivero S, Bre\u00f1a Atienza J, Gonz\u00e1lez D\u00e1vila E, et al. Eosinophil subtypes in adults with asthma and adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2023;208:155\u201362.","journal-title":"Am J Respir Crit Care Med"},{"key":"3234_CR81","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.2147\/COPD.S100338","volume":"11","author":"NA Negewo","year":"2016","unstructured":"Negewo NA, McDonald VM, Baines KJ, Wark PA, Simpson JL, Jones PW, et al. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1495\u2013504.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"3234_CR82","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1111\/all.16267","volume":"79","author":"M Fricker","year":"2024","unstructured":"Fricker M, Harrington J, Hiles SA, Gibson PG. Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma. Allergy. 2024;79:3118\u201328.","journal-title":"Allergy"},{"key":"3234_CR83","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3390\/cells12121631","volume":"12","author":"K Mycroft","year":"2023","unstructured":"Mycroft K, Papli\u0144ska-Goryca M, Proboszcz M, Nejman-Gryz P, Krenke R, G\u00f3rska K. Blood and sputum eosinophils of COPD patients are differently polarized than in asthma. Cells. 2023;12:1631.","journal-title":"Cells"},{"key":"3234_CR84","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3390\/cells9051248","volume":"9","author":"A Januskevicius","year":"2020","unstructured":"Januskevicius A, Jurkeviciute E, Janulaityte I, Kalinauskaite-Zukauske V, Miliauskas S, Malakauskas K. Blood eosinophils subtypes and their survivability in asthma patients. Cells. 2020;9:1248.","journal-title":"Cells"},{"key":"3234_CR85","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1111\/all.15884","volume":"78","author":"M Jesenak","year":"2023","unstructured":"Jesenak M, Diamant Z, Simon D, Tufvesson E, Seys SF, Mukherjee M, et al. Eosinophils-from cradle to grave: an EAACI task force paper on new molecular insights and clinical functions of eosinophils and the clinical effects of targeted eosinophil depletion. Allergy. 2023;78:3077\u2013102.","journal-title":"Allergy"},{"key":"3234_CR86","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1080\/10428194.2017.1330468","volume":"58","author":"N Droin","year":"2017","unstructured":"Droin N, Lucas N, Parinet V, Selimoglu-Buet D, Humbert M, Saada V, et al. Eosinophil-rich tissue infiltrates in chronic myelomonocytic leukemia patients. Leuk Lymphoma. 2017;58:2875\u20139.","journal-title":"Leuk Lymphoma"},{"key":"3234_CR87","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/cancers16020337","volume":"16","author":"RM Morales-Camacho","year":"2024","unstructured":"Morales-Camacho RM, Caballero-Vel\u00e1zquez T, Borrero JJ, Bernal R, Prats-Mart\u00edn C. Hematological neoplasms with eosinophilia. Cancers. 2024;16:337.","journal-title":"Cancers"},{"key":"3234_CR88","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/s41590-022-01291-2","volume":"23","author":"S Grisaru-Tal","year":"2022","unstructured":"Grisaru-Tal S, Rothenberg ME, Munitz A. Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy. Nat Immunol. 2022;23:1309\u201316.","journal-title":"Nat Immunol"},{"key":"3234_CR89","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/PAS.0000000000002160","volume":"48","author":"T Zhou","year":"2024","unstructured":"Zhou T, Wang HW, Ng SB, Summers T, Xi L, Raffeld M, et al. Tissue eosinophilia in B-cell lymphoma: an underrecognized phenomenon. Am J Surg Pathol. 2024;48:426\u201336.","journal-title":"Am J Surg Pathol"},{"key":"3234_CR90","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.5858\/arpa.2016-0223-RA","volume":"140","author":"DF Boyer","year":"2016","unstructured":"Boyer DF. Blood and bone marrow evaluation for eosinophilia. Arch Pathol Lab Med. 2016;140:1060\u20137.","journal-title":"Arch Pathol Lab Med"},{"key":"3234_CR91","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2217\/imt-2021-0149","volume":"14","author":"H Ghebeh","year":"2022","unstructured":"Ghebeh H, Elshenawy MA, AlSayed AD, Al-Tweigeri T. Peripheral blood eosinophil count is associated with response to chemoimmunotherapy in metastatic triple-negative breast cancer. Immunotherapy. 2022;14:189\u201399.","journal-title":"Immunotherapy"},{"key":"3234_CR92","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41573-023-00750-1","volume":"22","author":"P Kolkhir","year":"2023","unstructured":"Kolkhir P, Akdis CA, Akdis M, Bachert C, Bieber T, Canonica GW, et al. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs. Nat Rev Drug Discov. 2023;22:743\u201367.","journal-title":"Nat Rev Drug Discov"},{"key":"3234_CR93","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.mayocp.2021.04.025","volume":"96","author":"ME Wechsler","year":"2021","unstructured":"Wechsler ME, Munitz A, Ackerman SJ, Drake MG, Jackson DJ, Wardlaw AJ, et al. Eosinophils in health and disease: a state-of-the-art review. Mayo Clin Proc. 2021;96:2694\u2013707.","journal-title":"Mayo Clin Proc"},{"key":"3234_CR94","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1164\/rccm.202003-0729LE","volume":"202","author":"AM Moran","year":"2020","unstructured":"Moran AM, Ramakrishnan S, Borg CA, Connolly CM, Couillard S, Mwasuku CM, et al. Blood eosinophil depletion with mepolizumab, benralizumab, and prednisolone in eosinophilic asthma. Am J Respir Crit Care Med. 2020;202:1314\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"3234_CR95","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","volume":"383","author":"ES Dellon","year":"2020","unstructured":"Dellon ES, Peterson KA, Murray JA, Falk GW, Gonsalves N, Chehade M, et al. Anti-siglec-8 antibody for eosinophilic gastritis and duodenitis. N Engl J Med. 2020;383:1624\u201334.","journal-title":"N Engl J Med"},{"key":"3234_CR96","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jaci.2021.12.772","volume":"149","author":"S Altrichter","year":"2022","unstructured":"Altrichter S, Staubach P, Pasha M, Singh B, Chang AT, Bernstein JA, et al. An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria. J Allergy Clin Immunol. 2022;149:1683\u20131690.e7.","journal-title":"J Allergy Clin Immunol"},{"key":"3234_CR97","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S2213-2600(20)30053-9","volume":"8","author":"ID Pavord","year":"2020","unstructured":"Pavord ID, Holliday M, Reddel HK, Braithwaite I, Ebmeier S, Hancox RJ, et al. Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial. Lancet Respir Med. 2020;8:671\u201380.","journal-title":"Lancet Respir Med"},{"key":"3234_CR98","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/j.1365-2222.2005.02335.x","volume":"35","author":"M Malm-Erjef\u00e4lt","year":"2005","unstructured":"Malm-Erjef\u00e4lt M, Greiff L, Ankerst J, Andersson M, Wallengren J, Cardell LO, et al. Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation. Clin Exp Allergy. 2005;35:1334\u201340.","journal-title":"Clin Exp Allergy"},{"key":"3234_CR99","first-page":"199","volume":"9","author":"AM Schoepfer","year":"2024","unstructured":"Schoepfer AM, Safroneeva E. Pharmacologic treatment of eosinophilic esophagitis: efficacious, likely efficacious, and failed drugs. Inflamm Intest Dis. 2024;9:199\u2013209.","journal-title":"Inflamm Intest Dis"},{"key":"3234_CR100","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1080\/02770903.2021.1963769","volume":"59","author":"H Watanabe","year":"2022","unstructured":"Watanabe H, Shirai T, Hirai K, Akamatsu T, Nakayasu H, Tamura K, et al. Blood eosinophil count and FeNO to predict benralizumab effectiveness in real-life severe asthma patients. J Asthma. 2022;59:1796\u2013804.","journal-title":"J Asthma"},{"key":"3234_CR101","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/MCP.0000000000000536","volume":"25","author":"JS Erjef\u00e4lt","year":"2019","unstructured":"Erjef\u00e4lt JS. Unravelling the complexity of tissue inflammation in uncontrolled and severe asthma. Curr Opin Pulm Med. 2019;25:79\u201386.","journal-title":"Curr Opin Pulm Med"},{"key":"3234_CR102","doi-asserted-by":"publisher","first-page":"8139","DOI":"10.3390\/ijms25158139","volume":"25","author":"S Rojo-Tolosa","year":"2024","unstructured":"Rojo-Tolosa S, S\u00e1nchez-Mart\u00ednez JA, Caballero-V\u00e1zquez A, Pineda-Lancheros LE, Gonz\u00e1lez-Guti\u00e9rrez MV, P\u00e9rez-Ram\u00edrez C, et al. Single nucleotide polymorphisms as biomarkers of mepolizumab and benralizumab treatment response in severe eosinophilic asthma. Int J Mol Sci. 2024;25:8139.","journal-title":"Int J Mol Sci"},{"key":"3234_CR103","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.3390\/cells10102615","volume":"10","author":"S Esnault","year":"2021","unstructured":"Esnault S, Johansson MW, Mathur SK. Eosinophils, beyond IL-5. Cells. 2021;10:2615.","journal-title":"Cells"},{"key":"3234_CR104","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41577-024-01048-y","volume":"24","author":"IC Arnold","year":"2024","unstructured":"Arnold IC, Munitz A. Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and disease. Nat Rev Immunol. 2024;24:858\u201377.","journal-title":"Nat Rev Immunol"},{"key":"3234_CR105","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1056\/NEJMoa0805435","volume":"360","author":"P Nair","year":"2009","unstructured":"Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009;360:985\u201393.","journal-title":"N Engl J Med"},{"key":"3234_CR106","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.alit.2024.03.001","volume":"73","author":"C Venegas Garrido","year":"2024","unstructured":"Venegas Garrido C, Mukherjee M, Svenningsen S, Nair P. Eosinophil-mucus interplay in severe asthma: Implications for treatment with biologicals. Allergol Int. 2024;73:351\u201361.","journal-title":"Allergol Int"},{"key":"3234_CR107","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jaci.2024.03.023","volume":"154","author":"M Tang","year":"2024","unstructured":"Tang M, Charbit AR, Johansson MW, Jarjour NN, Denlinger LC, Raymond WW, et al. Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma. J Allergy Clin Immunol. 2024;154:580\u2013591.e6.","journal-title":"J Allergy Clin Immunol"},{"key":"3234_CR108","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1111\/all.14297","volume":"75","author":"KT Barretto","year":"2020","unstructured":"Barretto KT, Brockman-Schneider RA, Kuipers I, Basnet S, Bochkov YA, Altman MC, et al. Human airway epithelial cells express a functional IL-5 receptor. Allergy. 2020;75:2127\u201330.","journal-title":"Allergy"},{"key":"3234_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101799","volume":"69","author":"JA O\u2019Sullivan","year":"2023","unstructured":"O\u2019Sullivan JA, Youngblood BA, Schleimer RP, Bochner BS. Siglecs as potential targets of therapy in human mast cell- and\/or eosinophil-associated diseases. Semin Immunol. 2023;69:101799.","journal-title":"Semin Immunol"},{"key":"3234_CR110","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa2024257","volume":"385","author":"ME Wechsler","year":"2021","unstructured":"Wechsler ME, Ruddy MK, Pavord ID, Israel E, Rabe KF, Ford LB, et al. Efficacy and safety of itepekimab in patients with moderate-to-severe asthma. N Engl J Med. 2021;385:1656\u201368.","journal-title":"N Engl J Med"},{"key":"3234_CR111","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jaci.2023.05.014","volume":"152","author":"S Siddiqui","year":"2023","unstructured":"Siddiqui S, Wenzel SE, Bozik ME, Archibald DG, Dworetzky SI, Mather JL, et al. Safety and efficacy of dexpramipexole in eosinophilic asthma (EXHALE): a randomized controlled trial. J Allergy Clin Immunol. 2023;152:1121\u20131130.e10.","journal-title":"J Allergy Clin Immunol"},{"key":"3234_CR112","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jim.2004.02.008","volume":"288","author":"M Malm-Erjef\u00e4lt","year":"2004","unstructured":"Malm-Erjef\u00e4lt M, Stevens TR, Persson CG, Erjef\u00e4lt JS. Discontinuous Percoll gradient centrifugation combined with immunomagnetic separation obviates the need for erythrocyte lysis and yields isolated eosinophils with minimal granule abnormalities. J Immunol Methods. 2004;288:99\u2013109.","journal-title":"J Immunol Methods"},{"key":"3234_CR113","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/JLB.5MR0118-028R","volume":"104","author":"P Khoury","year":"2018","unstructured":"Khoury P, Akuthota P, Ackerman SJ, Arron JR, Bochner BS, Collins MH, et al. Revisiting the NIH Taskforce on the research needs of eosinophil-associated diseases (RE-TREAD). J Leukoc Biol. 2018;104:69\u201383.","journal-title":"J Leukoc Biol"},{"key":"3234_CR114","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/s41596-024-00967-3","volume":"19","author":"C Borrelli","year":"2024","unstructured":"Borrelli C, Gurtner A, Arnold IC, Moor AE. Stress-free single-cell transcriptomic profiling and functional genomics of murine eosinophils. Nat Protoc. 2024;19:1679\u2013709.","journal-title":"Nat Protoc"},{"key":"3234_CR115","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/cells14110847","volume":"14","author":"JS Erjef\u00e4lt","year":"2025","unstructured":"Erjef\u00e4lt JS. Spatial eosinophil phenotypes as immunopathogenic determinants in inflammatory diseases. Cells. 2025;14:847.","journal-title":"Cells"},{"key":"3234_CR116","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s43556-023-00144-0","volume":"4","author":"R Zhou","year":"2023","unstructured":"Zhou R, Yang G, Zhang Y, Wang Y. Spatial transcriptomics in development and disease. Mol Biomed. 2023;4:32.","journal-title":"Mol Biomed"},{"key":"3234_CR117","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cels.2024.07.001","volume":"15","author":"ATF Bell","year":"2024","unstructured":"Bell ATF, Mitchell JT, Kiemen AL, Lyman M, Fujikura K, Lee JW, et al. PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integration. Cell Syst. 2024;15:753\u2013769.e5.","journal-title":"Cell Syst"},{"key":"3234_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-08733-5","volume":"15","author":"L Wu","year":"2025","unstructured":"Wu L, Beechem JM, Danaher P. Using transcripts to refine image based cell segmentation with FastReseg. Sci Rep. 2025;15:30508.","journal-title":"Sci Rep"},{"key":"3234_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1470381","volume":"11","author":"A Sanchez Santos","year":"2025","unstructured":"Sanchez Santos A, Socorro Avila I, Galvan Fernandez H, Cazorla Rivero S, Lemes Castellano A, Cabrera Lopez C. Eosinophils: old cells, new directions. Front Med. 2025;11:1470381.","journal-title":"Front Med"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03234-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03234-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03234-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:04:54Z","timestamp":1791248694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03234-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3234"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03234-4","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors consent to publication.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"399"}}